Gastroesophageal reflux disease (GERD) affects an estimated 1.03 billion people worldwide, with prevalence ranging significantly by region. Defined as a condition where stomach contents reflux causes troublesome symptoms like heartburn and regurgitation, GERD’s diagnosis often involves endoscopy and reflux monitoring, especially for patients unresponsive to initial treatments. Advanced diagnostic tools such as pH or impedance-pH monitoring and high-resolution esophageal manometry help clinicians confirm GERD and assess for surgical suitability in more severe cases. Evolving treatments include tailored use of proton pump inhibitors (PPIs), novel medical therapies, and endoscopic procedures. Explore the full article for a comprehensive review of diagnostic and management strategies that are helping clinicians better address this pervasive condition.
Trending
- State laws may be curbing private equity takeovers of physician group (STAT)
- AI Shows Promise Across Spectrum of GI Motility Diagnostics, Review Finds (GI & Endoscopy News)
- Simple mouth rinse may help detect stomach and colorectal cancer signals (Medical Xpress)
- Vogenx IPO Raises $81M for Trial in Metabolic Disease With No Approved Drugs (MedCity News)
- Top AI in Endoscopy Companies Revolutionizing Real-Time Diagnostics and Intelligent Endoscopic Care (Fortune Business Insights)
- Rome V criteria capture more people with IBS, but a milder group (GI & Hepatology News)
- Real-World IBS Study Links IBS-Smart® and Trio-Smart® Testing to Lower Use of Selected Diagnostic Procedures and Lower Captured Diagnostic Costs (Business Wire)
- FITs Offer Lowest Environmental Footprint Among CRC Screening Options (AJMC)
